Table 2.
Patient‐related factors associated with initiation of insulin therapy
| Patient characteristics | OR (95% CI)a |
|---|---|
| Age (years) | |
| <40 | 2.274 (1.305–3.963) |
| 40 to <50 | 1.511 (1.019–2.240) |
| 50 to <60 | 1.345 (0.971–1.864) |
| ≥60 | 1.00 |
| Sex, n (%) | |
| Male | 0.802 (0.610–1.055) |
| Female | 1.00 |
| BMI (kg/m2) | |
| <25 | 1.00 |
| ≥25 | 0.961 (0.731–1.263) |
| HbA1c (%) | |
| <9% | 0.308 (0.235–0.404) |
| ≥9% | 1.00 |
| Duration of diabetes (years) | |
| <5 | 0.777 (0.553–1.090) |
| 5 to <10 | 0.643 (0.456–0.907) |
| ≥10 | 1.00 |
| History of microvascular complication | |
| Yes | 1.00 |
| No | 1.124 (0.842–1.500) |
| History of macrovascular complication | |
| Yes | 1.00 |
| No | 0.744 (0.525–1.056) |
a
Multivariate logistic regression.
BMI, body mass index; CI, confidence interval; HbA1c, glycated hemoglobin; OR, odds ratio.